The Radiant Logistics, Inc. 2021 Omnibus Incentive Plan (the “2021 plan”) permits the Company’s Audit and Executive Committee to grant share-based awards to eligible employees, non-employee directors, and consultants of the Company. The 2021 plan became effective immediately upon approval by the Company’s stockholders and will expire on November 16, 2031, unless terminated earlier by the Board. The 2021 plan replaced the 2012 Radiant Logistics, Inc. Stock Option and Performance Award Plan (the “2012 plan”). The remaining shares available for grant under the 2012 plan will roll over into the 2021 plan, and no new awards will be granted under the 2012 plan. The terms of the 2012 plan, as applicable, will continue to govern awards outstanding under the 2012 plan, until exercised, expired, paid or otherwise terminated or canceled. Other than the 2021 plan, there are no other equity compensation plans under which equity awards can be granted. As of June 30, 2025, there are 2,347,057 shares available for grant under the 2021 Plan.

The Company recognized share-based compensation benefit related to restricted stock units of $890 and share-based compensation expense of $2,540 for the fiscal years ended June 30, 2025 and 2024, respectively. As of June 30, 2025, the Company had approximately $2,294 of total unrecognized share-based compensation cost for restricted stock units expected to be recognized over a weighted average period of approximately 1.92 years.

The following table summarizes restricted stock unit activity:


	Number of Units			Weighted Average Grant Date Fair Value
Unvested balance as of June 30, 2024		1,553,127		$	6.63
Vested		(226,461	)		6.60
Granted		529,598			6.85
Forfeited		(388,207	)		7.05

Unvested balance as of June 30, 2025		1,468,057		$	6.60

The table above includes 892,578 and 870,252 PSUs with performance-based conditions as of June 30, 2025 and 2024, respectively. These awards will vest upon achievement of pre-established individual and Company performance goals as measured after a three-year period.

Stock options are granted at exercise prices equal to the fair value of the common stock at the date of the grant and have a term of ten years. Generally, grants under each plan vest 20% annually over a five-year period from the date of grant. The Company recognized share-based compensation expense related to stock options of $71 for each of the fiscal years ended June 30, 2025 and 2024. The aggregate intrinsic value of options exercised was $1,165 and $491, respectively, for the fiscal years ended June 30, 2025 and 2024. As of June 30, 2025, the Company had approximately $66 of total unrecognized share-based compensation cost for stock options expected to be recognized over a weighted average period of approximately 0.93 years.

The following table summarizes stock option activity:


	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)		Aggregate Intrinsic Value (In thousands)
Outstanding as of June 30, 2024		733,093		$	4.63		1.73	$	963
Exercised		(448,093	)		4.47		—		1,166

Outstanding as of June 30, 2025		285,000		$	4.89	2.54		$	476

Exercisable as of June 30, 2025		265,000		$	4.70		2.29	$	476

The following table summarizes outstanding and exercisable options by exercise price range as of June 30, 2025:


	Outstanding Options								Exercisable Options
Exercise Prices	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)		Aggregate Intrinsic Value (In thousands)		Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)		Aggregate Intrinsic Value (In thousands)
$3.00 − $3.99		160,000	$	3.39		0.78	$	431		160,000	$	3.39		0.78	$	431
$4.00 − $4.99		25,000		4.28		0.25		45		25,000		4.28		0.25		45
$7.00 − $7.99		100,000		7.45		5.93		—		80,000		7.45		5.93		—

		285,000	$	4.89		2.54	$	476	$	265,000	$	4.70		2.29	$	476